UltraGreen.Ai Wins Regulatory Nods In Philippines And Malaysia For Fluorescence-Guided Surgery Products

SGX Filings
Dec 30, 2025

UltraGreen.ai Limited (ULG) announced on Dec, 30 2025 that it has secured regulatory approval for its Verdye indocyanine green (ICG) injectable in the Philippines and for its IC-Flow Imaging System V2 in Malaysia.

The dual clearances conclude a multi-year regulatory process and advance the company’s strategy to expand fluorescence-guided surgery across Southeast Asia, a region experiencing rapid growth in healthcare demand.

Verdye provides surgeons with a high-quality ICG dye used in multiple surgical specialties, while the IC-Flow Imaging System V2 delivers real-time fluorescence imaging to support intra-operative decision-making.

With approvals in place, UltraGreen.ai and its local partners plan to step up education, training and broader clinical adoption of ICG-based techniques among surgeons in both countries.

The company is also developing an artificial-intelligence-powered data platform aimed at enhancing surgical decision support and standardising care across various procedures.

Headquartered in Singapore, UltraGreen.ai completed its initial public offering on the Singapore Exchange in Dec, 2025, raising US$400 million at a US$1.6 billion valuation.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10